Download P05 - Center for heart failure research

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

History of invasive and interventional cardiology wikipedia , lookup

Heart failure wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Electrocardiography wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Coronary artery disease wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Ventricular fibrillation wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Transcript
P05
Connective tissue growth factor inhibits myocardial growth, stimulates fibrosis, but
preserves myocardial function in chronic pressure overload
M. Shakil Ahmed1, Thomas von Lueder1,2, Jørgen A. Gravning1, Thor Edvardsen1,2, Erik Øie1,2, Birthe
Mikkelsen1, Otto A.Smiseth1,2, Håvard Attramadal1,2
1 Inst.
for Surgical Research and
of Cardiology, Rikshospitalet-Radiumhospitalet Medical Center and University of Oslo.
2 Dept.
Background: Myocardial expression of connective tissue growth factor (CTGF) is dramatically induced
in heart failure (HF) of diverse etiologies. However, the physiologic and pathophysiologic roles of
myocardial CTGF remain unresolved.
Methods and Results: To elucidate the actions of myocardial CTGF and its putative role in HF
transgenic mice with cardiac-restricted overexpression of CTGF were generated. Transgenic CTGF
(Tg-CTGF) mice had slightly lower cardiac mass than that of non-transgenic littermate controls (NLC)
(heart weight/tibia length of 4 months old male Tg-CTGF vs. NLC; 58.9±2.7 vs. 68.1±1.2 mg/cm,
p<0.05). Consistently, echocardiography revealed significantly smaller end-diastolic interventricular
septum thickness in Tg-CTGF. Simultaneous LV pressure-volume analysis did not disclose significant
alterations of contractility and cardiac output. Histochemical analysis of myocardial tissue revealed
interstitial fibrosis in Tg-CTGF mice. Increased myocardial collagen was confirmed by quantitation of
myocardial hydroxyproline contents by HPLC (1.10±0.03 vs.0.82±0.05 pmol/mg dry weight in TgCTGF vs. NLC mice; p<0.05). Consistently, increased myocardial procollagen--I and -III mRNA
levels in Tg-CTGF vs. NLC hearts were found. Morover, increased expression of antihypertrophic
TGF-2 and GDF-15 mRNA, and decreased expression of EGF mRNA in Tg-CTGF vs. NLC mice was
detected. Tg-CTGF and NLC mice were subjected to pressure overload by abdominal aortic banding
(AB) or sham-operation (SH). Four weeks after AB, significant elevations of cardiac mass were
observed both in Tg-CTGF-AB and NLC-AB mice. However, cardiac hypertrophy was significantly
diminished in Tg-CTGF-AB versus NLC-AB. Simultaneous PV-analysis provided evidence of cardiac
dysfunction in NLC-AB mice, i.e. significantly increased LVEDD, LVEDP, and decreased stroke
volume and cardiac output compared to NLC-SH mice. Strikingly, Tg-CTGF-AB revealed essentially
preserved LV pressure-volume relations. Elevations of myocardial BNP mRNA expression were
significantly attenuated in Tg-CTGF-AB compared to NLC-AB mice.
Conclusion: Myocardial CTGF causes interstitial fibrosis, but no evidence of restrictive cardiac
dysfunction, and preserves left ventricular function due to pressure overload.